Wed, March 24, 2021
Tue, March 23, 2021
Mon, March 22, 2021
Fri, March 19, 2021
Thu, March 18, 2021
Wed, March 17, 2021
Tue, March 16, 2021
Mon, March 15, 2021
Sun, March 14, 2021
Fri, March 12, 2021
Thu, March 11, 2021
Wed, March 10, 2021

Michael Morabito Maintained (AKRO) at Strong Buy with Increased Target to $81 on, Mar 17th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-81-on-mar-17th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Michael Morabito of Chardan Capital, Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Increased Target from $79 to $81 on, Mar 17th, 2021.

Michael has made no other calls on AKRO in the last 4 months.



There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Michael's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michael


  • Etzer Darout of "Guggenheim" Initiated at Strong Buy and Held Target at $54 on, Friday, February 26th, 2021

Publication Contributing Sources